Double maintains 2 strategies that include EYPT - EyePoint Pharmaceuticals, Inc.
Current Value
$5.361 Year Return
Current Value
$5.361 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PZA | 0.04% | $2.97B | 0.28% |
MMIT | 0.04% | $834.64M | 0.3% |
SPSK | 0.06% | $297.04M | 0.5% |
JMUB | 0.06% | $2.51B | 0.18% |
JAAA | 0.08% | $21.32B | 0.21% |
CCOR | 0.09% | $64.32M | 1.18% |
IBTF | 0.13% | $2.23B | 0.07% |
AGZ | -0.13% | $645.43M | 0.2% |
CGMU | 0.13% | $2.97B | 0.27% |
CARY | 0.19% | $347.36M | 0.8% |
UTEN | 0.19% | $187.56M | 0.15% |
TFI | 0.20% | $3.28B | 0.23% |
GOVT | 0.22% | $27.19B | 0.05% |
IBMO | -0.23% | $506.25M | 0.18% |
CORP | 0.24% | $1.32B | 0.23% |
DFNM | 0.26% | $1.51B | 0.17% |
BSMW | 0.27% | $100.91M | 0.18% |
IBTO | -0.31% | $331.70M | 0.07% |
FLGV | 0.32% | $964.26M | 0.09% |
TLH | -0.32% | $10.16B | 0.15% |
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Yahoo
WATERTOWN, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint, will participate in a fireside chat at the 2025 RBC Capital Markets Ophthalmology Conference on Friday, April 4, 2025 at 10:00 a.m. ET. A live webcast and subsequent
Yahoo
WATERTOWN, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an
Yahoo
Some of the losses seen by insiders who purchased US$184.5k worth of EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT...
Yahoo
Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call
Yahoo
Despite a challenging quarter, EyePoint Pharmaceuticals Inc (EYPT) progresses with promising clinical trials and a strong cash position.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 58.55% | $48.36M | 0.69% |
XBI | 47.07% | $5.07B | 0.35% |
GNOM | 46.70% | $48.63M | 0.5% |
ARKG | 44.29% | $963.54M | 0.75% |
RSPA | 44.12% | $292.30M | 0% |
IWC | 44.01% | $799.66M | 0.6% |
PBE | 43.46% | $229.91M | 0.58% |
XPH | 43.01% | $164.53M | 0.35% |
IBB | 42.06% | $5.74B | 0.45% |
IWO | 40.94% | $10.75B | 0.24% |
PTH | 40.89% | $111.59M | 0.6% |
IWM | 39.32% | $63.34B | 0.19% |
VTWO | 39.23% | $10.85B | 0.07% |
KAPR | 38.10% | $176.53M | 0.79% |
IZRL | 37.52% | $93.73M | 0.49% |
SCHA | 37.42% | $15.90B | 0.04% |
KJAN | 37.32% | $317.19M | 0.79% |
PRNT | 37.23% | $73.15M | 0.66% |
GSSC | 36.57% | $513.14M | 0.2% |
PBW | 36.33% | $212.11M | 0.65% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.45% | $414.68M | 1.43% |
VIXY | -18.00% | $195.31M | 0.85% |
TAIL | -17.48% | $86.59M | 0.59% |
WEAT | -14.46% | $115.01M | 0.28% |
YEAR | -13.53% | $1.28B | 0.25% |
TPMN | -11.52% | $33.32M | 0.65% |
UNG | -10.89% | $420.93M | 1.06% |
ULST | -9.24% | $587.14M | 0.2% |
JMST | -8.67% | $3.55B | 0.18% |
USDU | -8.19% | $207.14M | 0.5% |
UUP | -7.53% | $325.55M | 0.77% |
IYK | -7.52% | $1.52B | 0.4% |
TFLO | -7.16% | $6.78B | 0.15% |
DBE | -6.99% | $55.82M | 0.77% |
CORN | -6.76% | $51.42M | 0.2% |
BCI | -6.36% | $1.45B | 0.26% |
UGA | -5.61% | $89.99M | 0.97% |
DBC | -5.34% | $1.36B | 0.87% |
FTGC | -5.28% | $2.51B | 1.02% |
GSG | -5.11% | $1.05B | 0.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OCUL | 55.53% | $1.04B | -22.88% | 0.00% |
BEAM | 45.61% | $1.76B | -42.28% | 0.00% |
NTLA | 43.50% | $688.91M | -73.49% | 0.00% |
LAC | 42.09% | $602.72M | -60.85% | 0.00% |
PRCT | 41.04% | $3.13B | +22.62% | 0.00% |
DNLI | 40.36% | $1.78B | -36.58% | 0.00% |
NNOX | 40.13% | $282.56M | -51.31% | 0.00% |
RCKT | 40.05% | $619.52M | -77.39% | 0.00% |
RXRX | 40.01% | $2.05B | -41.90% | 0.00% |
ABCL | 39.73% | $622.79M | -51.62% | 0.00% |
ALEC | 38.35% | $114.94M | -80.07% | 0.00% |
AVXL | 37.77% | $682.21M | +76.65% | 0.00% |
CRSP | 37.64% | $2.84B | -49.04% | 0.00% |
DNTH | 37.54% | $540.67M | -36.94% | 0.00% |
RGNX | 36.95% | $338.58M | -66.68% | 0.00% |
RVMD | 36.56% | $6.25B | +8.73% | 0.00% |
KN | 36.44% | $1.33B | -5.90% | 0.00% |
SXI | 36.07% | $1.91B | -7.05% | 0.78% |
IMNM | 35.96% | $544.31M | -70.73% | 0.00% |
CLDX | 35.93% | $1.12B | -59.06% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KNOP | 0.01% | $261.00M | +44.13% | 1.38% |
G | -0.06% | $8.88B | +57.75% | 1.25% |
TR | -0.08% | $2.26B | +3.16% | 1.14% |
EIG | 0.09% | $1.25B | +14.28% | 2.36% |
BRO | 0.11% | $35.57B | +45.14% | 0.45% |
HIG | 0.11% | $35.50B | +22.12% | 1.61% |
SIGI | 0.11% | $5.59B | -12.39% | 1.60% |
GHI | -0.11% | $282.69M | -23.75% | 12.19% |
COO | 0.13% | $16.25B | -17.12% | 0.00% |
MITT | 0.18% | $216.51M | +22.28% | 10.68% |
CRESY | 0.19% | $688.55M | +28.88% | 8.74% |
BTI | -0.21% | $90.24B | +35.55% | 7.28% |
EQNR | -0.22% | $73.61B | +2.78% | 5.23% |
ABBV | -0.22% | $364.89B | +14.16% | 3.05% |
NNN | 0.22% | $7.99B | +2.39% | 5.42% |
AMH | -0.24% | $13.94B | +4.41% | 2.88% |
ADC | 0.28% | $8.25B | +35.19% | 3.92% |
OHI | 0.30% | $10.73B | +22.49% | 7.05% |
EG | 0.30% | $15.69B | -6.75% | 2.20% |
ADM | 0.32% | $23.15B | -23.11% | 4.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -25.57% | $23.56B | +23.21% | 1.08% |
ED | -16.54% | $38.86B | +21.48% | 3.03% |
T | -15.83% | $204.43B | +62.56% | 3.91% |
PGR | -15.21% | $166.65B | +35.36% | 1.73% |
ACGL | -14.24% | $36.12B | +10.51% | 0.00% |
AEP | -12.85% | $57.87B | +27.18% | 3.33% |
ALL | -12.84% | $54.99B | +20.26% | 1.82% |
PEP | -12.58% | $205.27B | -12.70% | 3.61% |
FE | -11.35% | $23.30B | +5.02% | 4.20% |
VZ | -11.34% | $191.04B | +6.68% | 5.93% |
PG | -11.19% | $399.94B | +6.22% | 2.36% |
TRVG | -10.92% | $101.97M | +63.74% | 0.00% |
MO | -10.61% | $99.39B | +36.94% | 6.89% |
POST | -10.21% | $6.62B | +11.85% | 0.00% |
DUK | -10.08% | $94.07B | +25.41% | 3.43% |
PM | -10.08% | $245.81B | +72.17% | 3.39% |
LRN | -9.77% | $5.62B | +109.47% | 0.00% |
EXC | -9.75% | $46.36B | +22.19% | 3.35% |
ES | -9.67% | $22.79B | +4.76% | 4.65% |
CME | -9.59% | $94.51B | +22.09% | 3.99% |